Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
The development of vaccines plays a vital role in the effective control of several fatal diseases. However, effective prophylactic and therapeutic vaccines have yet to be developed for completely curing deadly diseases, such as cancer, malaria, HIV, and serious microbial infections. Thus, suitable v...
Main Authors: | Veena Vijayan, Adityanarayan Mohapatra, Saji Uthaman, In-Kyu Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/10/534 |
Similar Items
-
Self-adjuvanting cancer nanovaccines
by: Zhiyun Liao, et al.
Published: (2022-07-01) -
Research progress of nanovaccine in anti-tumor immunotherapy
by: Min Yao, et al.
Published: (2023-08-01) -
Injectable host-guest gel nanovaccine for cancer immunotherapy against melanoma
by: Kaige Xu, et al.
Published: (2022-08-01) -
Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine
by: Junqing Wang, et al.
Published: (2020-07-01) -
Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
by: Hu Chen, et al.
Published: (2022-06-01)